Board Meeting19 May 2026, 07:22 pm
Anthem Biosciences Approves FY26 Financial Results; ₹2 Dividend
AI Summary
Anthem Biosciences Ltd's Board approved standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. They recommended a final dividend of ₹2.00 per equity share, subject to shareholder approval. The 20th Annual General Meeting will be held on July 22, 2026. The board also approved the allotment of 14,81,250 equity shares under the Anthem Employee Stock Option Plan 2024 and re-appointed M/s. BPU & Co. as Internal Auditors. They recommended the continuation of Mr. Ravikant Uppal as Non-Executive Independent Director and the re-appointment of Mr. Ravindra Chandrappa as Whole Time Director, both subject to shareholder approval.
Key Highlights
- Approved audited standalone and consolidated financial results for FY26.
- Recommended a final dividend of ₹2.00 per share, pending shareholder approval.
- Approved allotment of 14,81,250 equity shares under ESOP 2024.
- Re-appointed M/s. BPU & Co. as Internal Auditors for FY27.
- Recommended continuation/re-appointment of directors, subject to AGM approval.
Price Impact
More from ANTHEM